Lessons from a review of thyroglobulin assays in the management of thyroid cancer

Internal Medicine Journal

Volumn 38, Issue 6 A, 2008, Pages 441-444

  Wong, J ^a   Lu, Z ^a   Doery, J ^a,b   Fuller, P ^a,c  

^a Southern Health ^*  (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Differentiated thyroid cancer; Thyroglobulin assays; Tumour marker

Indexed keywords

THYROGLOBULIN; TUMOR MARKER;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; FOLLOW UP; HORMONE DETERMINATION; HUMAN; MEASUREMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; THYROID CANCER; TUMOR DIFFERENTIATION;

DISEASE PROGRESSION; HUMANS; IMMUNOASSAY; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 45749136399     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01658.x     Document Type: Article

References (10)

1. AACE/AAES. AACE/AAES medical/surgical guidelines for clinical practice: the management of thyroid carcinoma. Endocrine Practice 2001 7 : 202 20.
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 16 : 109 42.
3. Royal College of Physicians, eds. Guidelines for the Management of Thyroid Cancer in Adults, 2002. London : British Thyroid Association 2002.
4. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006 154 : 787 803.
5. Coleman PM, Babb P, Damiecki P, Groslaude P, Honjo S, Jones J et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS region. London : The Stationery Office 1999 Series SMPS No.: 61.
6. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma (Comment). J Clin Endocrinol Metab 2003 88 : 1433 41.
7. Iervasi A, Iervasi G, Carpi A, Zucchelli GC. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact. Biomed Pharmacother 2006 60 : 414 24.
8. Spencer CA, Bergoglio M, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005 90 : 5566 75.
9. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007 92 : 82 7.
10. Zophel K, Wunderlich G, Smith BR. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid 2003 13 : 861 5.